The Division on Substance Abuse of the Columbia University Department of Psychiatry and the New York State Psychiatric Institute is applying for continuation of a 2-year post-doctoral program that trains physicians and clinical psychologists for research careers in substance abuse. The goal is to provide both the research skills and clinical expertise necessary to design and carry out research on the etiology and treatment of substance use disorders. The program includes the following elements: 1) Didactic introduction to clinical research in the addictions including core seminars on a) substance abuse treatment and research; b) introduction to biostatistics; and c) methodology seminar and d) electives in biostatistics or methodology from the School of Public Health; 2) Clinical experience in the major modalities used to treat substance abuse; 3) Research apprenticeship: Each trainee works as a junior collaborator under the close supervision of a senior investigator who serves as preceptor and mentor. The trainee assists with ongoing projects to gain experience in the relevant research methods and designs and carries out independent research projects; and 4) Graduated development of teaching capabilities. Applicants are required to have completed an approved residency training program in psychiatry or a related clinical discipline and to demonstrate excellence in clinical work, motivation for an academic/research career, and a well-focused interest in substance abuse. The environment for research training includes a broad range of clinical populations and treatment modalities, and an extensive ongoing program of funded research on addictions. Clinical facilities include inpatient and outpatient clinics at the New York State Psychiatric Institute, the Presbyterian Hospital, the St. Lukes-Roosevelt Hospital, the Bridge Plaza Treatment and Rehabilitation Service, the Addiction Treatment and Research Corporation, Smithers Rehabilitation Center, and Phoenix House. Research fields represented by our preceptors' groups include basic neuroscience, genetics, genetic epidemiology, behavioral pharmacology, epidemiology, psychopharmacology, clinical trials, and treatment research. In its first four years, the program has had a steady flow of high quality applicants, and has hosted 7 trainees, four psychiatrists, one neurologist, and two clinical psychologists. Five have graduated, three going on to full time academic-research positions, and two to academic-clinical positions. Two psychiatrists will begin training in July 1997. The program has been successful in recruiting women and minority trainees.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007294-10
Application #
6515471
Study Section
Special Emphasis Panel (ZDA1-MXS-M (06))
Program Officer
Montoya, Ivan
Project Start
1993-07-20
Project End
2003-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
10
Fiscal Year
2002
Total Cost
$162,189
Indirect Cost
Name
Columbia University (N.Y.)
Department
Psychiatry
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Brezing, Christina A; Choi, C Jean; Pavlicova, Martina et al. (2018) Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder. Am J Addict 27:101-107
Shulman, Matisyahu; Campbell, Aimee; Pavlicova, Martina et al. (2018) Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment. Am J Addict 27:509-515
Brezing, Christina A; Levin, Frances R (2018) The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology 43:173-194
Luo, Sean X; Wall, Melanie; Covey, Lirio et al. (2018) Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder. Am J Drug Alcohol Abuse 44:653-659
Notzon, Daniel P; Kelly, Meredith A; Choi, C Jean et al. (2018) Open-label pilot study of injectable naltrexone for cannabis dependence. Am J Drug Alcohol Abuse 44:619-627
Aharonovich, Efrat; Campbell, Aimee N C; Shulman, Matisyahu et al. (2018) Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders. J Addict Med 12:99-106
Kidd, Jeremy D; Jackman, Kasey B; Wolff, Margaret et al. (2018) Risk and Protective Factors for Substance Use among Sexual and Gender Minority Youth: A Scoping Review. Curr Addict Rep 5:158-173
Ait-Daoud, Nassima; Hamby, Allan Scott; Sharma, Sana et al. (2018) A Review of Alprazolam Use, Misuse, and Withdrawal. J Addict Med 12:4-10
Williams, Arthur Robin; Santaella-Tenorio, Julian; Mauro, Christine M et al. (2017) Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder. Addiction 112:1985-1991
Williams, Arthur Robin; Barbieri, Vincent; Mishlen, Kaitlyn et al. (2017) Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders. Am J Addict 26:319-325

Showing the most recent 10 out of 90 publications